Abstract
The development and prescription of drugs that alter the hemostatic balance marked an important breakthrough in the treatment and prevention of thromboembolic events, which has drastically reduced the associated morbidity and mortality. The discovery of heparin and coumarin anticoagulants, as well as the description of their thrombotic activities, opened a new therapeutic scenario.
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
